复方苦参注射液单独用于晚期肺癌的治疗
【摘要】目的:观察复方苦参注射液对晚期肺癌的临床疗效与kps评分的影响。方法:随机选取56例晚期肺癌患者,静脉滴注复方苦参注射液,观察近期肿瘤客观疗效,生活质量。结果:复方苦参注射液治疗肿瘤的近期稳定率为59.0%%;治疗后较治疗前KPS评分提高26例(35.7%),稳定40例(64.3%)。结论:复方苦参注射液单独使用对晚期肺癌的有较好的疗效,且可以改善患者生存质量。
【关键词】复方苦参注射液;晚期肺癌;KPS评分
【abstract 】objective: to observe the clinical curative effect of compound sophora injection with advanced lung cancer and the influence of the KPS score. Methods: 56 cases of advanced lung cancer patients were randomly selected, the group to be treated with compound matrine injection ......
您现在查看是摘要页,全文长 4512 字符。